Publication: 4743

Publication: 4743

Inotuzumab ozogamicin then blinatumomab for older adults with newly-diagnosed, Ph-negative, CD22-positive, B-cell ALL: Extended follow up of Alliance A041703 reveals durable remission and survival

Google Scholar

Citation:

Meeting Instance:: ASH 2025
Year:: 2025
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Matthew J. Wieduwilt Jun Yin Oudom Kour Rebecca Teske Wendy Stock Carolin Escherich Jun Yang Zhenhua Li Kenneth Byrd Kimberley Doucette James Mangan Scott Hall Alice S. Mims Katarzyna Jamieson Shira N. Dinner Ali W. Bseiso Giorgia Giordano Caner Saygin Geoffrey L. Uy Mark R. Litzow Richard M. Stone

Networks:: CA249, CAPITAL, CHRISTIANA, KANSAS, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OH007, NC002, WINCORP

Study: Alliance-A041703
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: